Table 2 Basic study and patient characteristics.
Study characteristics | Patient characteristics | ||||||
|---|---|---|---|---|---|---|---|
First author | Year | Type of reference | Design of study | No. of patients | Age (years) | Cancer type | Stage (n) |
Shioyama19 | 2007 | Article | Retrospective | 16 | 62 (median, range 40–77) | NSCLC | IIIA (3), IIIB (8), IV (3), recurrent (2) |
Yin29 | 2009 | Article | Prospective | 10 | NS | NSCLC | NS |
Munawar22 | 2010 | Article | Retrospective | 10 | NS | NSCLC | III |
McGuire18 | 2010 | Article | Retrospective | 5 | NS | Lung cancer | NS |
St-Hilaire15 | 2011 | Article | Retrospective | 15 | NS | Lung cancer | II (1), III (11), limited stage of SCLC (3) |
Agrawal17 | 2012 | Article | Retrospective | 11 | NS | NSCLC | Locally advanced |
Liu35 | 2013 | Conference | Retrospective | 23 | NS | Lung cancer | NS |
Wang23 | 2013 | Article | Prospective | 39 | 61(median, range 34–77) | NSCLC | IIIA (20), IIIB (19) |
Lukovic21 | 2014 | Conference | Retrospective | 21 | NS | NSCLC | III |
Meng36 | 2014 | Article | Prospective | 15 | 57–86 (range) | NSCLC | II (3), III (12) |
Tian20 | 2014 | Article | Retrospective | 10 | 61 (median, range 42–80) | NSCLC | I-III |
Far3 | 2015 | Article | Prospective | 58 | 67 (median, range 43–84) | NSCLC | I-II (5), III (36), IV (3), recurrent (14) |
Siva25 | 2015 | Article | Prospective | 20 | 68 (median, range 47–90) | NSCLC | I (5), II (2), III (11), IV (2) |
Siva24 | 2016 | Article | Prospective | 14 | 65 (median, range 47–90) | NSCLC | I (5), II (1), III (7), IV (1) |
Xiao4 | 2018 | Article | Prospective | 42 | NS | NSCLC | IIIA (19), IIIB (23) |
